EUVIMEDEUVIMED entdecken
Crossref

Pharmacist-driven outcomes for patients on oral oncology medications: clinical impact of an integrated specialty pharmacy model

Kishen Patel, Martha Stutsky, Caleb Chun, Shreevidya Periyasamy, Chelsey Lindner

NCODA Oncology and Hematology Meeting Abstracts · 15.06.2026

DOI: 10.67209/amqc7198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NCODA Oncology and Hematology Meeting Abstracts, online erschienen am 15.06.2026. Verfasst von Kishen Patel und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral oncology medications have been increasingly utilized; however, these therapies often involve complex regimens, intricate dosing schedules, and challenging side effect profiles, all of which contribute to patient nonadherence, therapy disruptions, and increased healthcare costs. To address these challenges, many health systems have implemented integrated specialty pharmacy (HSSP) models, which optimize coordination of care and offer comprehensive patient support. The objective of this evaluation was to highlight the impact of this type of care model on prescription adherence and clinical outcomes within a patient population filling oral oncology medications through a HSSP.

Zitieren

APA

Patel, K., Stutsky, M., Chun, C., Periyasamy, S., & Lindner, C. (2026). Pharmacist-driven outcomes for patients on oral oncology medications: clinical impact of an integrated specialty pharmacy model. NCODA Oncology and Hematology Meeting Abstracts. https://doi.org/10.67209/amqc7198

Vancouver

Patel K, Stutsky M, Chun C, Periyasamy S, Lindner C. Pharmacist-driven outcomes for patients on oral oncology medications: clinical impact of an integrated specialty pharmacy model. NCODA Oncology and Hematology Meeting Abstracts. 2026. doi:10.67209/amqc7198

BibTeX
@article{Patel2026,
  author = {Patel, Kishen and Stutsky, Martha and Chun, Caleb and Periyasamy, Shreevidya and Lindner, Chelsey},
  title = {Pharmacist-driven outcomes for patients on oral oncology medications: clinical impact of an integrated specialty pharmacy model},
  journal = {NCODA Oncology and Hematology Meeting Abstracts},
  year = {2026},
  doi = {10.67209/amqc7198}
}
Kostenlos starten →